Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
210.1 USD | -0.73% | -5.95% | +2.10% |
Apr. 15 | Morgan Stanley Adjusts Primerica's Price Target to $250 From $245, Keeps Equalweight Rating | MT |
Mar. 19 | Primerica Insider Sold Shares Worth $365,115, According to a Recent SEC Filing | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.10% | 7.29B | B | ||
-11.07% | 90.51B | B- | ||
-1.49% | 88.33B | B | ||
+15.99% | 72.74B | D+ | ||
-30.79% | 68.42B | B+ | ||
+2.06% | 28.53B | B | ||
+12.62% | 27.18B | B | ||
+2.31% | 26.58B | A | ||
+0.14% | 17.46B | C+ | ||
-7.60% | 15.59B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRI Stock
- Ratings Primerica, Inc.